ArticleProceedings of the National Academy of Sciences of the United States of America2024

A classic antibiotic reimagined: Rationally designed bacitracin variants exhibit potent activity against vancomycin-resistant pathogens.

Ned P Buijs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.